ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:41 am Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,291,701 2.240% | -1,663,299 (-56.29%) | Filing |
| 2023-04-13 4:30 pm Purchase | 2023-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,955,000 5.440% | 1,804,955 (+156.95%) | Filing |
| 2021-02-11 08:05 am Sale | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,150,045 2.690% | -1,049,955 (-47.73%) | Filing |
| 2020-05-22 4:30 pm Purchase | 2020-05-13 | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,200,000 6.390% | 2,200,000 (New Position) | Filing |